Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Nuvation Bio (NUVB)
NYSE:NUVB
Nuvation Bio (NUVB) Stock Price & Analysis
67 Followers
NUVB Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.52 - $4.31
Previous Close$1.69
Volume460.97K
Average Volume (3M)534.59K
Market Cap
$371.47M
Enterprise Value-$271.17M
Total Cash (Recent Filing)$646.61M
Total Debt (Recent Filing)$3.97M
Price to Earnings (P/E)-3.5
Beta0.94
Next Earnings
Aug 10, 2023EPS Estimate
-$0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.48
Shares Outstanding218,803,722
10 Day Avg. Volume427,176
30 Day Avg. Volume534,586
Standard Deviation0.14
R-Squared0.05
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)0.55
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-4.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda2.30
Forecast
1Y Price Target
$4.83Price Target Upside180.81% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Nuvation Bio News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
NUVB FAQ
What was Nuvation Bio’s price range in the past 12 months?
Nuvation Bio lowest stock price was $1.52 and its highest was $4.31 in the past 12 months.
What is Nuvation Bio’s market cap?
Currently, no data Available
When is Nuvation Bio’s upcoming earnings report date?
Nuvation Bio’s upcoming earnings report date is Aug 10, 2023 which is in 64 days.
How were Nuvation Bio’s earnings last quarter?
Nuvation Bio released its earnings results on May 04, 2023. The company reported -$0.1 earnings per share for the quarter, the consensus estimate of -$0.1 by $0.
Is Nuvation Bio overvalued?
According to Wall Street analysts Nuvation Bio’s price is currently Undervalued.
Does Nuvation Bio pay dividends?
Nuvation Bio does not currently pay dividends.
What is Nuvation Bio’s EPS estimate?
Nuvation Bio’s EPS estimate is -$0.11.
How many shares outstanding does Nuvation Bio have?
Nuvation Bio has 218,803,730 shares outstanding.
What happened to Nuvation Bio’s price movement after its last earnings report?
Nuvation Bio reported an EPS of -$0.1 in its last earnings report, expectations of -$0.1. Following the earnings report the stock price went up 3.086%.
Which hedge fund is a major shareholder of Nuvation Bio?
Among the largest hedge funds holding Nuvation Bio’s share is Omega Fund Management, LLC. It holds Nuvation Bio’s shares valued at 25M.
---
Nuvation Bio Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$4.83 (180.81% Upside)
$4.83 (180.81% Upside)
Blogger Sentiment
Bearish
NUVB Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 5.4M Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-54.44%
12-Months-Change
Fundamentals
Return on Equity
-15.33%
Trailing 12-Months
Asset Growth
-12.60%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Nuvation Bio
Panacea Acquisition Corp is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
---
Top 5 ETFs holding NUVB
Vanguard Health Care ETF
$664.41K
Schwab U.S. Broad Market ETF
$113.96K
Fidelity MSCI Health Care Index ETF
$103.81K
iShares Russell 3000 ETF
$75.00K
BMO MSCI Innovation Index ETF
$2.63K
Up to five ETFs with an Outperform Smart Score that hold NUVB. The ETFs are listed according to market value of NUVB within the ETF
---
---